Table 4.
Availability of malaria commodities in the private sector
| Private for-profit health facility | Pharmacy | Drug store | General retailer | Itinerant drug vendor | All private sector | |
|---|---|---|---|---|---|---|
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
| Among all screened outlets, availability of | N = 668 | N = 290 | N = 338 | N = 23,840 | N = 924 | N = 26,060 |
| Any anti-malarial | 31.0 (26.1, 36.3) | 20.5 (14.8, 27.6) | 6.6 (4.2, 10.1) | 0.2 (0.1, 0.4) | 15.1 (11.4, 19.8) | 1.8 (1.5, 2.1) |
| Among anti-malarial-stocking outlets or outlets stocking anti-malarials in the past 3 months, availability of | N = 237 | N = 74 | N = 34 | N = 39 | N = 186 | N = 570 |
| Diagnostics | ||||||
| Any malaria blood testing | 83.0 (76.8, 87.8) | 70.1 (58.2, 79.7) | 60.9 (40.8, 77.9) | 0.0 (–) | 60.4 (50.6, 69.4) | 64.7 (58.5, 70.3) |
| Malaria microscopy | 15.6 (10.9, 22.0) | 4.8 (1.6, 13.1) | 4.0 (0.6, 21.7) | 0.0 (–) | 5.6 (3.2, 9.8) | 8.7 (6.4, 11.9) |
| RDT | 81.3 (74.8, 86.5) | 70.1 (58.2, 79.7) | 60.9 (40.8, 77.9) | 0.0 (–) | 59.8 (50.0, 68.9) | 63.8 (57.6, 69.6) |
| Among anti-malarial stocking outlets, availability of | N = 186 | N = 45 | N = 22 | N = 29 | N = 109 | N = 391 |
| Anti-malarials | ||||||
| Any first-line ACT | 90.0 (82.5, 94.5) | 85.6 (74.3, 92.4) | 47.9 (27.8, 68.6) | 2.8 (0.5, 15.6) | 62.8 (51.7, 72.7) | 70.9 (63.1, 77.6) |
| DHA PPQ | 90.0 (82.5, 94.5) | 85.6 (74.3, 92.4) | 47.9 (27.8, 68.6) | 2.8 (0.5, 15.6) | 62.8 (51.7, 72.7) | 70.9 (63.1, 77.6) |
| ASMQ FDC | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) |
| Primaquine | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) |
| Chloroquine | 4.6 (2.0, 10.3) | 7.7 (2.9, 19.1) | 20.5 (9.7, 38.1) | 67.1 (27.6, 91.6) | 30.7 (20.1, 43.7) | 19.7 (14.1, 26.9) |
| Other non-artemisinin therapy | 1.3 (0.3, 5.4) | 0.0 (–) | 6.8 (1.9, 21.4) | 0.0 (–) | 1.8 (0.6, 5.2) | 1.5 (0.7, 3.3) |
| Oral AMT | 0.0 (–) | 0.0 (–) | 0.0 (–) | 2.3 (0.4, 12.7) | 0.0 (–) | 0.2 (0.0, 1.2) |
| IV/IM artesunate | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.0 (–) | 0.7 (0.1, 4.0) | 0.2 (0.0, 1.3) |
| Availability of first-line ACT and malaria blood testing | 80.4 (72.6, 86.3) | 67.1 (52.5, 79.0) | 23.6 (10.0, 46.1) | 0.0 (–) | 50.8 (40.2, 61.3) | 59.4 (51.9, 66.6) |
| Availability of first-line ACT, blood testing not available | 9.6 (6.1, 15.0) | 18.5 (10.5, 30.5) | 24.3 (9.4, 49.9) | 2.8 (0.5, 15.6) | 12.0 (7.0, 19.9) | 11.5 (8.4, 15.4) |